In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection - Wikidata - wikimedia - TriplyDB

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

http://www.wikidata.org/entity/Q41767104

about

Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug Targets In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents.In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci.

P2860

Q27678160-B279EA3E-C6E1-4AC5-84C9-D4373109C5B7 Q28551788-F1903E9A-84AD-4834-BDD0-6E456E9028F4 Q33559139-0A9B88CD-1A30-4C60-961C-7FF04FC02CC9 Q34658467-4FB2929D-E35F-4EC7-B424-7D1049E5AD19 Q34797629-2B9D562A-68C5-4CF6-9F1D-897D6B3D2933 Q36969769-D7D73364-44BA-413D-B798-E589E03714D8 Q37145603-66C4491C-60AD-449F-946A-23858A85934C Q37190797-D27F83E4-0E42-440D-AAE4-FF3D4067796D Q40760998-08B52289-8594-490A-B8C2-D6CB2B054B88

P2860

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

http://www.wikidata.org/entity/Q41767104

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

@en

type

label

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

@en

prefLabel

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

@en

P1433

Q41767104-549F5D7B-B617-40DE-B371-9FE99637CB1B

P1476

Q41767104-32373287-DAC0-42E5-96BE-227F5183286D

P2093

Q41767104-26CF878C-9F93-482D-A0EE-5F223BE5ED93

Q41767104-3352D32A-DDD0-4D41-A6C7-E5C175A7B877

Q41767104-53301E84-4C3A-47DF-8EB4-3574B09F557E

Q41767104-5E5C995E-9EEE-41F4-9160-2D73E8A08617

Q41767104-9D49B738-41C6-40B3-929A-475FCB3394A1

Q41767104-B3AA6689-39B1-45D1-A18E-35757E206F04

P2860

Q41767104-02963F99-1104-48FC-9B80-6F494BCF5707

Q41767104-0A3F672B-0C78-4802-964E-72445AC38978

Q41767104-1EFA1FB7-0FA0-45CF-B7F5-DA78CBFE9C25

Q41767104-358119DE-0E69-4755-BB5F-C0C7B183CC0E

Q41767104-5C387158-3B1A-4073-9592-83FEADF5EE65

Q41767104-5C680A5C-7C79-4150-91D4-8C252C4FD356

Q41767104-94D6D0CF-47D9-49B3-8268-736C04F1A8AF

Q41767104-99F5D0E3-4248-4194-BF90-FA37AFC37668

Q41767104-9E365591-85A1-42D4-86F2-3C18756C49C7

Q41767104-A39A7D27-05D5-4E2E-95D7-B2564CC17028

P304

Q41767104-CABA153C-A721-4706-B939-427733A47C32

P31

Q41767104-79AFC034-169B-4963-8AE1-790F71A92B32

P356

Q41767104-3AC32E14-EF90-42E7-B4E3-739645F15CC3

P407

Q41767104-C15F340E-2898-4B47-8C99-7C9F116A82E2

P433

Q41767104-C9375DF6-2A47-4B2B-9B12-759959E4E9FD

P478

Q41767104-C235ABAE-DE3E-4241-9DC5-DD7804A6B391

P577

Q41767104-3D6E62D5-7C5A-4B67-B256-715CF37CF6A6

P5875

Q41767104-2117FF1C-D551-46F8-8E8D-098584166897

P698

Q41767104-963602DD-B8AA-4349-B3FC-4DDF30979FBC

P932

Q41767104-8C28DED2-0A5A-4B4E-96B0-0ED312D09C8B

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection

@en

P2093

Amy M Flattery

http://www.w3.org/2001/XMLSchema#string

Andrew S Misura

http://www.w3.org/2001/XMLSchema#string

Charles J Gill

http://www.w3.org/2001/XMLSchema#string

Emily J Hickey

http://www.w3.org/2001/XMLSchema#string

George K Abruzzo

http://www.w3.org/2001/XMLSchema#string

Ken Bartizal

http://www.w3.org/2001/XMLSchema#string

P2860

The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria

Oxazolidinones: a review

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

Thrombocytopenia associated with linezolid therapy.

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

Linezolid-resistant enterococci: report of the first isolates in the United Kingdom.

Linezolid--a review of the first oxazolidinone.

Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.

Antimicrobial resistance issues of the future.

P304

3434-3436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01567-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6230442

http://www.w3.org/2001/XMLSchema#string

P698

17606686

http://www.w3.org/2001/XMLSchema#string

P932

2043186

http://www.w3.org/2001/XMLSchema#string